Imaging AI in North Carolina

Topia MedTech Limited develops wearable diagnostics and AI-powered imaging solutions for clinical use. The company's flagship products are FibriArt, a continuous ECG monitoring patch for cardiac arrhythmia detection and remote patient monitoring, and Alzevita, an AI-based MRI segmentation and volumetry software tool for brain imaging analysis. FibriArt captures medical-grade single-lead ECG signals and provides insights into heart health, including atrial fibrillation (AFib) and atrial flutter (AFL) detection, designed for cardiologists and physicians. Alzevita automates hippocampal segmentation and volumetric reporting for radiologists and imaging labs, improving workflow efficiency and delivering reproducible imaging insights for neurodegenerative disease assessment and clinical decision-making. Both products target healthcare professionals seeking data-driven diagnostic tools. The company maintains a multi-regional presence with headquarters in North Carolina (USA) and additional offices in the UK (London), India (Ahmedabad, Vadodara), Mexico, and the EU (Ireland, Spain, Portugal, Romania). Topia MedTech positions itself as advancing smart, accessible medical technology through wearable devices and AI-powered software solutions.

Calla Health Foundation is a medical device company focused on improving women's access to cervical cancer prevention and screening, particularly in low-resource settings. The organization develops portable, affordable diagnostic imaging technologies and AI-driven decision support systems designed to democratize gynecological examination and cancer prevention. Their product suite includes the Pocket Colposcope (a portable, low-cost video colposcope for cervical tissue examination), the Callascope (a speculum-free cervical imaging device enabling self-screening or provider-assisted insertion), and CARE (an AI algorithm for cervical pre-cancer risk assessment). The company's innovations enable midwives and community health workers to perform point-of-care screening and "see-and-treat" management paradigms without requiring traditional hospital infrastructure or specialized physician expertise. FDA-cleared and clinically validated in multiple low- and middle-income countries.

Laboratory Corporation of America Holdings (Labcorp) is a global leader in laboratory services headquartered in Burlington, North Carolina. Operating in approximately 100 countries with over 70,000 employees, Labcorp performs more than 700 million tests annually and generates $13.01 billion in revenue. The company provides comprehensive clinical diagnostics, drug development support, and specialized testing including oncology, rare diseases, and genomic sequencing. Labcorp's integrated platform connects diagnostics to biopharma development, supporting healthcare providers, researchers, and investigators. Key offerings include AI-powered diagnostic assistance tools, real-world data platforms for drug development, genetic testing services (including Invitae), nonclinical research, central laboratory services, and clinical trial support. The company serves patients, healthcare providers, health systems, managed care organizations, and biopharmaceutical companies. Over 75% of new drugs approved by the FDA have been supported by Labcorp's services.

Intelerad Medical Systems is a leading provider of cloud-based medical imaging software and enterprise workflow solutions established in 1999. The company specializes in scalable PACS (Picture Archiving and Communication Systems), diagnostic imaging viewing, AI-enhanced reporting, secure image sharing, and clinical workflow orchestration. Intelerad's platform manages over 50 billion medical images and supports more than 300,000 clinicians conducting 140+ million exams annually. Key product offerings include IntelePACS® for image archival and management, InteleViewer™ for zero-footprint diagnostic viewing, InteleShare for secure patient imaging exchange, InteleOrchestrator for AI-powered clinical worklist prioritization, and InteleGence AI tools for precision diagnostics assistance. The company serves nearly 2,500 healthcare organizations globally—including radiology groups, hospitals, cardiology practices, and outpatient imaging centers—with operations across six countries and over 900 employees.

Convergent Imaging Solutions develops advanced image fusion and nuclear medicine software solutions for healthcare facilities. The company's flagship product, UniSyn MI™ software, provides comprehensive image fusion capabilities across multiple modalities including PET/CT, SPECT/CT, and PET/MR imaging. UniSyn MI supports local, remote, and hybrid deployment models with seamless PACS integration and configurable viewing and processing options. The software serves four primary clinical specialties: oncology (diagnosis, staging, recurrence detection, and treatment response evaluation), general nuclear medicine (planar, gated, and dynamic imaging analysis), cardiology (leveraging partnerships with Cedars-Sinai for cardiac processing), and neurology (neuroradiology imaging). The company also provides radiopharmaceutical dosimetry solutions for theranostic applications including metastatic neuroendocrine tumors, differentiated thyroid cancer, metastatic prostate cancer, and primary/metastatic liver disease. Convergent Imaging Solutions emphasizes workflow optimization, customizable solutions tailored to individual facility needs, and dedicated expert support. The company has received FDA 510(k) clearance for its MRT Dosimetry module. Based in Ottawa, Ontario, Canada, the company supports radiology and nuclear medicine professionals globally, serving as a workflow-optimized software provider for precision diagnostic imaging.

TeraRecon, Inc. is a healthcare software company specializing in AI-powered advanced medical imaging visualization and enterprise image management solutions. The company delivers SaaS-based platforms—TeraRecon AV (registered as Intuition globally) and TeraRecon DETECT—that combine advanced 3D visualization with AI-driven automation to enhance diagnostic precision and clinical workflow efficiency. Products support radiology, cardiology, neurology, vascular surgery, and oncology applications with features including medical image viewing, AI biomarker detection, real-time decision support, and enterprise imaging consolidation. Founded in 1997 and based in Durham, North Carolina, TeraRecon serves approximately 1,900 clinical sites globally with ~195-244 employees and ~$41M annual revenue. The platform emphasizes interoperability, enabling integration with existing hospital imaging systems while automating routine interpretation tasks and reducing clinician time-to-diagnosis.